Cooperative evolution of mechanisms of β-lactam resistance

Clinical Microbiology and Infection

Volumn 6, Issue S3, 2000, Pages 27-33

  Medeiros, A A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; GENTAMICIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULFONE DERIVATIVE; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL MEMBRANE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; HYDROGEN BOND; IN VIVO STUDY; KLEBSIELLA; NONHUMAN; POINT MUTATION; SOIL MICROFLORA; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; GRAM NEGATIVE INFECTION; INFANT; METABOLISM; MOLECULAR EVOLUTION; PROTEIN CONFORMATION; REVIEW;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; EVOLUTION, MOLECULAR; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; PROTEIN CONFORMATION;

EID: 0034571865     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2000.tb02037.x     Document Type: Article

References (20)

1. Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997; 24(Suppl. 1): S19-45.
2. Elena SF, Cooper VS, Lenski RE. Punctuated evolution caused by selection of rare beneficial mutations. Science 1996; 272: 1802-4.
3. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.
4. Casellas JM, Goldberg M. Incidence of strains producing extended spectrum beta-lactamases in Argentina. Infection 1989; 17: 434-6.
5. Kuzin AP, Nukaga M, Nukaga Y, Hujer AM, Bonomo RA, Knox JR. Structure of the SHV-1 beta-lactamase. Biochemistry 1999; 38: 5720-7.
6. Naumovski L, Quinn JP, Miyashiro D et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992; 36: 1991-6.
7. Hibbert-Rogers LC, Heritage J, Todd N, Hawkey PM. Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity. J Antimicrob Chemother 1994; 33: 707-20.
8. Knox JR. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure. Antimicrob Agents Chemother 1995; 39: 2593-601.
9. Knox JR, Moews PC, Frere JM. Molecular evolution of bacterial beta-lactam resistance. Chem Biol 1996; 3: 937-47.
10. Palzkill T, Botstem D. Probing beta-lactamase structure and function using random replacement mutagenesis. Protein-Struct Funct Genet 1992; 14: 29-44.
11. Bush K, Sykes RB. Interaction of beta-lactam antibiotics with beta-lactamases as a cause for resistance. In Anonymous. Antimicrobial Drug Resistance. London: Academic Press. 1984, pp. 1-31.
12. Herzberg O, Moult J. Bacterial resistance to beta-lactam antibiotics crystal structure of beta-lactamase from Staphylococcal aureus PCI at 2.5 A Resolution. Science 1987; 236: 694-701.
13. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
14. IMP, among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother 1995; 39: 824-9.
15. Casellas JM, Blanco MG, Pinto ME. The sleeping giant. Antimicrobial resistance. Infect Dis Clin North Am 1994; 8: 29-45.
16. Vahaboglu H, Öztürk R, Aygün G et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41: 2265-9.
17. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 1989; 33: 1831-6.
18. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
19. Rasheed JK, Jay C, Metchock B et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41: 647-53.
20. Petit A, Yaghlane-Bouslama H Ben, Sofer L, Labia R. Does high level production of SHV-type penicillinase confer resistance to ceftazidime in enterobacteriaceae. FEMS Microbiol Lett 1992; 92: 89-94.